Brachytherapy for nasal vestibule cancer: dose and technique
Part of Cancer, Ear, nose & throat clinical trials.
This study looks at using a type of internal radiation therapy, called brachytherapy, as the only treatment for a specific type of skin cancer in the nostril area. The goal is to find the best dose and technique to improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a type of skin cancer called squamous cell carcinoma in the nasal vestibule (the front part of the nostril)
- Your cancer is at an early to moderate stage (Rome stage 1-4 or Wang stage T1-T3)
- You have had imaging tests (like ultrasound, PET/CT, or MRI) to check if the cancer has spread to the neck
- You are able to undergo a brachytherapy procedure and attend follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a special type of internal radiation (called image-guided brachytherapy) for women with vaginal cancer. It aims to give high doses directly to the tumor while limiting side effects to nearby organs.
This study looks at survival and outcome factors for people who have squamous cell carcinoma in the nasal vestibule. It uses information from surgery and scans and checks tissue samples to see what predicts recovery or risk of problems later.
This trial tests whether shrinking the area that gets radiation in the nasal cavity can reduce side effects while still treating the cancer effectively. If you have nasopharyngeal cancer that has spread into your nose, this study might help lower radiation exposure to that area.
This study tests whether giving a lower radiation dose to the vagina during brachytherapy (internal radiation) is safe and works as well as the standard dose for people with cervical cancer that has not spread to the vagina. It aims to reduce side effects while still treating the cancer effectively.
This trial tests a special type of internal radiation (brachytherapy) for people with low-lying rectal cancer that did not fully go away after standard chemoradiation and chemotherapy. The goal is to shrink the remaining tumor enough to avoid major surgery like removing the rectum or colostomy.
This trial tests combining brachytherapy (a type of internal radiation) with immunotherapy (nivolumab) for people with advanced esophageal cancer that has not fully responded to initial chemoradiation. The goal is to see if this targeted approach can improve outcomes.
Hear when a new Carcinoma Nasal Vestibule trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.